2024-08-27T10:10:39-05:00 2023-12-31 910189318 MOSS ADAMS LLP 101 SECOND STREET SUITE 900 SAN FRANCISCO CA 94105 990 2023-01-01 273868699 AMERICAN GLAUCOMA SOCIETY FOUNDATION AMER 4155618587 655 BEACH STREET SAN FRANCISCO CA 94109 GREGORY L SKUTA MD EXECUTIVE VICE PRESIDENT 4155618587 2024-08-26 1 0 MICHAEL LUMSDEN P01262236 4159561500 2024-08-26 2023 2024-08-08 14:25:15Z CARLA J SIEGFRIED MD 655 BEACH STREET SAN FRANCISCO CA 94109 280385 0 X WWW.AMERICANGLAUCOMASOCIETY.NET X 2010 CA TO SUPPORT GLAUCOMA RESEARCH AND EDUCATION, AND TO PROMOTE EXCELLENCE IN THE CARE OF PATIENTS WITH GLAUCOMA. 23 23 0 32 0 0 156026 278423 0 0 1376 1790 0 0 157402 280213 290000 200000 0 0 0 0 0 0 0 16387 36774 306387 236774 -148985 43439 331194 381521 6673 5675 324521 375846 TO SUPPORT GLAUCOMA RESEARCH AND EDUCATION, AND TO PROMOTE EXCELLENCE IN THE CARE OF PATIENTS WITH GLAUCOMA. 0 0 150000 150000 0 AGSF PROVIDED AGS $150,000 IN FUNDING TO SUPPORT RESEARCH AND EDUCATION PROGRAMS SPONSORED BY AGS AIMED AT MAKING A SIGNIFICANT IMPACT IN THE FIGHT TO PREVENT BLINDNESS AND VISUAL IMPAIRMENT. EXAMPLES INCLUDE: (I) GRANTS TO YOUNG CLINICIAN SCIENTISTS TO ENCOURAGE THE DEVELOPMENT OF YOUNG CLINICIAN SCIENTISTS IN GLAUCOMA BY PROVIDING FUNDING FOR RESEARCH PROJECTS WITHIN THE FIRST 5 YEARS AFTER GRADUATION, AND (II) GRANTS TO MID-CAREER PHYSICIAN SCIENTISTS TO ALLOW MID-CAREER (BETWEEN 5 AND 20 YEARS AFTER FELLOWSHIP) TO INITIATE NEW RESEARCH OR CONTINUE ONGOING RESEARCH. 50000 50000 0 AGSF PROVIDED AGS $50,000 IN FUNDING TO SUPPORT AGS CARES WHICH IS A PUBLIC SERVICE PROGRAM SUPPORTED BY THE AGS FOUNDATION THAT IS DEDICATED TO PROVIDING SURGICAL GLAUCOMA CARE AT NO COST TO UNINSURED OR UNDER-SERVED PATIENTS WHO QUALIFY FOR SUCH CARE. THE GLAUCOMA CARE IS PROVIDED BY MEMBERS OF A NATIONAL NETWORK OF VOLUNTEERS COMPRISING GLAUCOMA SURGEONS WHO ARE AGS ACTIVE OR PROVISIONAL MEMBERS. 972 0 0 AGSF PROVIDED SUPPORT TO OUTSIDE ORGANIZATIONS (THE FOUNDATION OF THE AMERICAN ACADEMY OF OPHTHALMOLOGY) WORKING CLOSELY WITH EYE HEALTH TO SUPPORT OPERATIONS. 200972 1 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 X 23 23 0 1 0 0 1 1 0 1 1 0 0 1 1 1 1 1 1 0 0 0 AL AK AR CA CO CT DC FL GA HI IL KS KY ME MD MA MI MN MS NV NH NJ NM NY NC ND OH OK OR PA RI SC TN UT VA WA WV WI X WAJHMA ABOUD 4155618587 655 BEACH STREET SAN FRANCISCO CA 94109 X CHRISTOPHER A GIRKIN MD MSPH PRES THRU 3/2023 / PAST PRESIDENT 1.00 1.00 X X 0 0 0 LEON W HERNDON JR MD VP THRU 3/2023 / PRES START 3/2023 1.00 1.00 X X 0 0 0 CARLA J SIEGFRIED MD VP START 3/2023 1.00 1.00 X X 0 0 0 LISA FRAN ROSENBERG MD TREASURER THRU 3/2023 1.00 1.00 X X 0 0 0 DAVID G GODFREY MD TREASURER START 3/2023 1.00 1.00 X X 0 0 0 JOANN A GIACONI MD SECRETARY 1.00 1.00 X X 0 0 0 LAMA A AL-ASWAD MD MPH MEMBER-AT-LARGE 1.00 1.00 X 0 0 0 WALLACE LM ALWARD MD MEMBER-AT-LARGE THRU 3/2023 1.00 0.00 X 0 0 0 JAMES D BRANDT MD MEMBER-AT-LARGE THRU 3/2023 1.00 0.00 X 0 0 0 DONALD L BUDENZ MD MPH PAST PRESIDENT THRU 3/2023 1.00 1.00 X 0 0 0 LOUIS B CANTOR MD MEMBER-AT-LARGE THRU 3/2023 1.00 0.00 X 0 0 0 CATHY G COHEN MEMBER-AT-LARGE START 3/2023 1.00 0.00 X 0 0 0 ANNE L COLEMAN MD MEMBER-AT-LARGE START 3/2023 1.00 0.00 X 0 0 0 GEOFFREY T EMERICK MD PATIENT COMMITTEE CHAIR 1.00 1.00 X 0 0 0 RONALD L FELLMAN MD PAST PRESIDENT 1.00 1.00 X 0 0 0 ANN CAROLINE FISHER MD DEI COMMITTEE CHAIR START 3/2023 1.00 1.00 X 0 0 0 YING HAN MD RESEARCH COMM CHAIR START 3/2023 1.00 1.00 X 0 0 0 RICHARD K LEE MD PHD RESEARCH COMM CHAIR THRU 3/2023 1.00 1.00 X 0 0 0 MICHELE C LIM MD PROGRAM COMMITTEE CHAIR 1.00 1.00 X 0 0 0 STEVEN L MANSBERGER MD MPH MEMBER-AT-LARGE START 3/2023 1.00 0.00 X 0 0 0 FELIPE A MEDEIROS MD PHD BYLAWS/STRAT PLANNING COMM CHAIR 1.00 1.00 X 0 0 0 KELLY W MUIR MD EDUCATION AND COMMUNICATION CHAIR 1.00 1.00 X 0 0 0 PETER A NETLAND MD PHD MEMBER-AT-LARGE START 3/2023 1.00 0.00 X 0 0 0 MILDRED MG OLIVIER MD MEMBER-AT-LARGE THRU 3/2023 1.00 1.00 X 0 0 0 ROMA PATEL MD MEMBER-AT-LARGE START 3/2023 1.00 1.00 X 0 0 0 DOUGLAS J RHEE MEMBER-AT-LARGE START 3/2023 1.00 1.00 X 0 0 0 KULDEV SINGH MD MPH MEMBER-AT-LARGE THRU 3/2023 1.00 0.00 X 0 0 0 SAMUEL P SOLISH MD COUNCILOR TO AAO 1.00 1.00 X 0 0 0 ANGELA V TURALBA MD MMS MEMBER-AT-LARGE 1.00 1.00 X 0 0 0 THASARAT S VAJARANANT MD LEAD AMBASSADOR 1.00 1.00 X 0 0 0 KATEKI VINOD MD MEMBER-AT-LARGE 1.00 1.00 X 0 0 0 JANEY WIGGS MD PHD NOMINATING COMM CHAIR THRU 3/2023 1.00 1.00 X 0 0 0 0 0 0 0 0 0 0 0 278423 278423 1902 1902 60 172 -112 -112 -112 280213 0 0 1790 200000 200000 7050 7050 8926 8926 4820 4820 626 626 972 972 14380 14380 236774 200972 35802 0 229987 233131 0 30000 74839 87633 26368 30757 331194 381521 6673 5675 6673 5675 X 319521 277796 5000 98050 324521 375846 331194 381521 43439 7886 0 X 0 1 X 1 0 X 252739 253549 358752 156026 278423 1299489 252739 253549 358752 156026 278423 1299489 513500 785989 1319 9821 1234 1253 1902 15529 1315018 0.59770 0.45350 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 DUE FROM RELATED ORGANIZATION 30757 30757 1 AMERICAN GLAUCOMA SOCIETY INC 655 BEACH STREET SAN FRANCISCO CA 94109 222765077 501(C)(3) 200000 0 RESEARCH, MENTORING, AND PUBLIC SERVICE GRANTS 1 0 PART I, LINE 2: THE ORGANIZATION'S BOARD IS INTIMATELY INVOLVED WITH THE WORK OF THE GRANT RECIPIENT, AMERICAN GLAUCOMA SOCIETY, INC. (AGS). THE BOARD OF DIRECTORS OF AGS IS COMPRISED SOLELY OF MEMBERS WHO ALSO SIT ON THE BOARD OF AGSF; THUS, GRANTS TO AGS ARE MONITORED VIA OVERLAPPING GOVERNANCE. FORM 990, PART VI, SECTION A, LINE 3 AGSF HAS A MANAGEMENT CONTRACT WITH SAN FRANCISCO ASSOCIATION MANAGEMENT SERVICES (SF-AMS). UNDER THE ANNUAL CONTRACT, ALL PERSONNEL DECISIONS AND FINANCIAL OPERATIONS ARE THE RESPONSIBILITY OF SF-AMS. FORM 990, PART VI, SECTION A, LINE 6 THE ORGANIZATION DOES NOT HAVE "MEMBERS" BY DEFINITION OF THE BYLAWS. HOWEVER, THE FORM 990 INSTRUCTIONS DEFINE A "MEMBER" AS ANY PERSON (INCLUDING A CORPORATION OR OTHER LEGAL ENTITY) WHO, PURSUANT TO A PROVISION IN THE ORGANIZATION'S GOVERNING DOCUMENTS, HAS THE RIGHT TO PARTICIPATE IN THE ORGANIZATION'S GOVERNANCE, INCLUDING ELECTING MEMBERS OF THE GOVERNING BODY. ACCORDINGLY, AGSF HAS ONE SOLE MEMBER: AMERICAN GLAUCOMA SOCIETY, INC. FORM 990, PART VI, SECTION A, LINE 7A ALL OF THE DIRECTORS OF THE AMERICAN GLAUCOMA SOCIETY, INC. (AGS), A CALIFORNIA NONPROFIT CORPORATION EXEMPT FROM FEDERAL INCOME TAX UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE, SHALL AUTOMATICALLY BE DIRECTORS OF THIS CORPORATION, BUT ONLY FOR SO LONG AS THEY REMAIN DIRECTORS OF AGS. THE DIRECTORS OF AGS MAY ALSO APPOINT UP TO FIVE ADDITIONAL DIRECTORS TO THE BOARD OF AGSF. FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 IS PREPARED BY AN OUTSIDE TAX PROFESSIONAL. THE FORM IS THEN REVIEWED BY THE FINANCE AND ACCOUNTING STAFF OF THE ORGANIZATION'S MANAGEMENT COMPANY, WITH QUESTIONS REFERRED TO THE OUTSIDE TAX PROFESSIONAL. AFTER A FULL REVIEW (WITH MODIFICATIONS WHERE NECESSARY), THE FINAL VERSION OF THE FORM 990 IS PROVIDED TO ALL MEMBERS OF THE ORGANIZATION'S VOTING GOVERNING BODY PRIOR TO FILING WITH THE INTERNAL REVENUE SERVICE. FORM 990, PART VI, SECTION B, LINE 12C IT IS THE POLICY OF THE BOARD OF DIRECTORS OF AGSF THAT ITS DIRECTORS DISCLOSE AND, DEPENDING ON THE CIRCUMSTANCES, AVOID ANY AND ALL POSSIBLE CONFLICTS OF INTEREST. A DIRECTOR HAS A CONFLICT OF INTEREST WHEN A PERSON OR A MEMBER OF HIS OR HER FAMILY HAS A RELATIONSHIP WITH, OR AN INTEREST IN, AN ENTITY THAT DOES BUSINESS WITH AGSF OR IS A COMPETITOR OF AGSF. THIS POLICY IS IMPLEMENTED AND ENFORCED SO AS TO PREVENT THE JUDGMENT OF THE BOARD FROM BEING INFLUENCED BY AN ECONOMIC RELATIONSHIP IN WHICH A DIRECTOR OF HIS/HER FAMILY IS PERSONALLY INVOLVED. DIRECTORS SATISFY TWO OBLIGATIONS IN REGARDS TO THIS CONFLICT OF INTEREST POLICY: (1) ASCERTAINING AND DISCLOSING THEIR OWN FAMILY CONFLICTS, AND (2) DETERMINING WHETHER ANOTHER INVOLVED PERSON SHOULD PARTICIPATE IN DELIBERATIONS AND/OR VOTING ON AN ISSUE WITH RESPECT TO WHICH HE/SHE HAS A CONFLICT. A DIRECTOR WILL DISCLOSE ANY CONFLICT AT BOARD MEETINGS AND RECUSE THEMSELVES IF SUCH CONFLICT EXISTS. TO ACCOMPLISH AND FULFILL THIS POLICY, ALL DIRECTORS ANNUALLY SUBMIT A DISCLOSURE STATEMENT, AND ARE RESPONSIBLE FOR UPDATING THE STATEMENT IF CHANGES OCCUR DURING THE YEAR. FORM 990, PART VI, SECTION C, LINE 19 AGSF MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. AMERICAN GLAUCOMA SOCIETY INC 655 BEACH STREET SAN FRANCISCO CA 94109 222765077 TO PROMOTE THE IMPROVEMENT AND EXCHANGE OF GLAUCOMA-RELATED INFORMATION CA 501(C)(3) LINE 10 N/A 1 0 1 0 1 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 AMERICAN GLAUCOMA SOCIETY INC B 200000 BOOK VALUE